alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Oncology 2—Translational Clinical Integrated Review Group; Cancer Biomarkers Study Section.                    

*Date:*                         February 11-12, 2019.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Ritz Carlton Hotel, 1150 22nd Street NW, Washington, DC 20037.                    

*Contact Person:*                         Lawrence Ka-Yun Ng, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD 20892, 301-357-9318,                         *ngkl@csr.nih.gov*.                    

This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: January 22, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00234 Filed 1-29-19; 8:45 am]

BILLING CODE 4140-01-P
B.C.D. 00-41

OCT 2 3 2000

EMPLOYER STATUS DETERMINATION

Beaufort and Morehead Railway, Incorporated

This is the determination of the Railroad Retirement Board concerning the

continued status of Beaufort and Morehead Railway, Incorporated (BA number 

5557) as an employer under the Railroad Retirement Act (45 U.S.C. § 231 et

seq.) and the Railroad Unemployment Insurance Act (45 U.S.C. § 351 et

seq.).

The Beaufort and Morehead Railway (B&M Railway) was held to be an employer

under the Acts effective February 4, 1991, when it assumed operation of

approximately 3 miles of rail line between Morehead City and Beaufort, 

North Carolina. Ownership of the rail line remained with the Beaufort and

Morehead Railroad (B&M Railroad) . See B.C.D. No. 95-46.1

By letter dated March 7, 2000, Mr. William C. Taylor, General Manager of

the North Carolina Ports Railway Commission (Railway Commission) reported

to the Chief of the Board's Audit and Compliance Section that the Surface

Transportation Board had approved the acquisition of the lease and

operation of the railway line by the Railway Commission, which intended to

do business as Beaufort and Morehead Railway. See: North Carolina Ports 

Railway Commission d/b/a Beaufort & Morehead Railway—Acquisition and

Operation Exemption—Beaufort & Morehead Railway, Inc., STB Finance Docket

No. 33826, 64 Fed. Reg. 67619, December 2, 1999. Mr. Taylor further stated 

that the Commission began operations over the line on January 1, 2000.

Regulations of the Board provide that the employer status of a company

shall terminate whenever the company loses any of the characteristics

essential to the existence of an employer status. See 20 CFR 202.11. The

Board previously determined the B&M Railway to be a covered employer on the

basis of operation of the Beaufort - Morehead City rail line under lease.

Because the obligations of the B&M Railway to operate the line were assumed 

effective January 1, 2000 by the Railway Commission, the Board finds that

the status of the Beaufort & Morehead Railway as a covered employer under

the Acts terminated with the close of business on December 31, 1999.

1 The B&M Railroad was itself owned by the North Carolina Ports Railway

Commission. On April 1, 1997, ownership of the B&M Railroad was transferred

to the North Carolina Department of Transportation (NC Dot). One year later,

on April 1, 1998, B&M Railroad merged with North Carolina Railroad (BA

No.8055) as part of a transaction whereby NC DoT gained 100 percent control of

the North Carolina Railroad. The B&M Railroad then ceased to exist as a

corporate entity. B&M Railroad functioned throughout its history as merely

title holder to the rail line, and never conducted rail operations itself.

BA# 5557
#### § 200.104 Standard reference materials.

Often the performance of a device or structure can be evaluated at the user's laboratory by comparing its response to unknown materials with its response to a stable, homogeneous reference specimen which has been well-characterized with regard to the physical or chemical property being measured. For information regarding carefully characterized materials see Subchapter B, Chapter II, Part 230, of this title. The Office of Standard Reference Materials in the NIST National Measurement Laboratory administers a program to provide many types of well-characterized materials that are needed to calibrate a measurement system or to produce scientific data that can be readily referred to a common base. NIST SP 260 is a catalog of Standard Reference Materials available from NIST.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Department of the Navy

# AGENCY:

Department of the Navy, DoD.

# ACTION:

Notice.

# SUMMARY:

The Department of the Navy (DoN) announces the availability of the inventions listed below, assigned to the United States Government, as represented by the Secretary of the Navy, for domestic and foreign licensing by the Department of the Navy.

# ADDRESSES:

Requests for copies of the patents cited should be directed to Naval Surface Warfare Center, Crane Div., Code OOL, Bldg. 2, 300 Highway 361, Crane, IN 47522-5001.

# FOR FURTHER INFORMATION CONTACT:

                        Mr. Christopher Monsey, Naval Surface Warfare Center, Crane Div., Code OOL, Bldg. 2, 300 Highway 361, Crane, IN 47522-5001, Email                         *Christopher.Monsey@navy.mil,*                         812-854-2777.                    

# SUPPLEMENTARY INFORMATION:

The following patents are available for licensing: Patent No. 10,156,426 (Navy Case No. 102280): APPARATUS AND METHODS FOR PARALLEL TESTING OF DEVICES// and Patent No. 10,161,979 (Navy Case No. 103102): SYSTEM FOR PRECIPITATION-STATIC CHARGE LEVEL ESTIMATION FOR SURFACE DAMAGE TO DIELECTRICALLY COATED SURFACES.

      ( print page 677)    Authority: 35 U.S.C. 207, 37 CFR part 404.

Dated: January 28, 2019.

M.S. Werner, 

Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register Liaison Officer.

[FR Doc. 2019-00373 Filed 1-30-19; 8:45 am]

 BILLING CODE 3810-FF-P
#### In the Matter of John A. Lyons, as Commissioner of Correction of the State of New York, Appellant. George H. Rowe, as Judge of the County Court of Erie County, Respondent; Anthony Mangano, Intervener, Respondent.

Present — Crosby, P. J., Cunningham, Taylor, Dowling and McCurn, JJ.
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of Victoria Industries, Inc. a
Nevada corporation (the "Company") on Form 10-KSB/A for the period ending
December 31, 2005, as filed with the Securities and Exchange Commission on the
date hereof (the "Report"), Albert Abdoulline, Principal Executive Officer and
the Principal Financial Officer of the Company, certifies to the best of his
knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of
the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of Section 13(a)
          or 15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

     A signed original of this written statement required by Section 906 has
been provided to Victoria Industries, Inc., and will be retained by Victoria
Industries, Inc. and furnished to the Securities and Exchange Commission or its
staff upon request.


Date: March 8, 2007
                                   By:  /s/ Albert Abdoulline
                                        ------------------------------------
                                        Albert Abdoulline
                                        Chairman, President, Chief Executive
                                        Officer and Chief Financial Officer
C OURT OF A PPEALS FOR THE

F IRST D ISTRICT OF T EXAS AT H OUSTON

O RDER

Appellate case name: In re Friede & Goldman, LLC f/k/a FGL Buyer, LLC d/b/a

Friede & Goldman, Ltd.

Appellate case number: 01

- 1 8

- 00 4 0 9

- CV

Trial court case number: 2 0 1 6

- 29340

Trial court: 125th District Court of Harris County

Relato r

, Friede & Goldman, LLC f/k/a FGL Buyer, LLC d/b/a Fr ie de & Goldman,

Ltd. , ha s filed a petition for a writ of mandamus in this Court

. R elator also ha s filed a

“M otion for Emergency Order Staying Trial Court Discovery. ” The motion is denied

.

It is so ORDERED.

Judge’s signature: /s/ Russell Lloyd

 Acting individually  Acting for the Court

Date: June 21 , 2018
#### § 1500.62 Patents, copyrights, trademarks, information, publications, and product formulations.

Ownership and allocation of rights to patents, copyrights, inventions, or publications, developed through the use of non-Federal funds remitted to the Board under the Order shall be determined by written agreement between the Board and the party(ies) receiving funds for the development of such inventions, patents, copyrights or publications.
[Federal Register Volume 84, Number 20 (Wednesday, January 30, 2019)]
[Notices]
[Page 476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00287]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-18-012 NIDDK Program 
Projects (P01).
    Date: February 8, 2019.
    Time: 11:30 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ann A. Jerkins, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, <a href="/cdn-cgi/l/email-protection#39535c4b5250574a587957505d5d5217575051175e564f"><span class="__cf_email__" data-cfemail="9bf1fee9f0f2f5e8fadbf5f2fffff0b5f5f2f3b5fcf4ed">[email protected]</span></a>.

    This meeting notice is being published less than 15 days in 
advance of the meeting due to the partial Government shutdown of 
December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: January 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00287 Filed 1-29-19; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32


                            CERTIFICATION PURSUANT TO

                             18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO

                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


      In connection with the Annual report of eRoomSystem Technologies, Inc.
(the "Company") on Form 10-KSB for the fiscal year ended December 31, 2006 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), David A. Gestetner, Chairman, President, Chief Executive Officer and
Secretary (Principal Executive Officer and Principal Accounting and Financial
Officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


/s/ David A. Gestetner     President, Chief Executive Officer,    March 26, 2007
----------------------     Secretary and Chairman of the Board
David A. Gestetner         (Principal Executive Officer and
                           Principal Financial and Accounting Officer)
#### Miller et al. v. Commonwealth ex rel. Dummit, Attorney General.

October 24, 1947.

Lawrence F. Speekman, Judge.

W. S. Heidenburg for appellants.

Eldon S. Dummit, Attorney General, Frank A. Ropke and Charles E. Keller for appellee.

Opinion of the Court by

Stanley, Commissioner

—Affirming.

The injunction in this case is against substantially the same persons as in Miller, Sr., v. Commonwealth, 306 Ky. 269, 206 S. W. 2d 958 and the facts are as in Goose v. Commonwealth, 305 Ky. 644, 205 S. W. 2d 326. The gambling establishment is known as the “South Downs Cafe.” It is situated on the corner of Fourth and Winkler Sts. and designated as 2629-2633 South Fourth St. in Louisville. The property is owned by Coleman Miller, Sr., and his son, Coleman Miller, Jr. has been in active charge. There is no doubt, real or imaginary, that the father knew all that was going on at this place and there is no special defense.

On authority of Goose v. Commonwealth, supra, the judgment is affirmed.
<PAGE>
                                                                   Page 12 of 20

                                                                   EXHIBIT 99(e)

                        KEYCORP STUDENT LOAN TRUST 1999-B

                              OFFICER'S CERTIFICATE


Banker's Trust Company, Deutsche Bank         Key Bank USA, National Association
100 Plaza One, Mailstop: JCY03-6450           800 Superior Avenue, 4th Floor
Jersey City, NJ 07310                         Cleveland, Ohio 44114
ATTN: Corporate Trust & Agency Group          ATTN: Senior Vice President
      Structured Finance                      Key Education Resources
Phone: (201) 593-6776                         Phone: (216) 828-9342
Fax: (201) 593-6459                           Fax: (216) 828-9301


Pursuant to Section 3.09 of the Indenture between KeyCorp Student Loan Trust
1999-B, as Issuer, and Bankers Trust Company, as Indenture Trustee, dated
September 1, 1999, the undersigned hereby certifies that (i) a review of the
activities of the Issuer from January 1, 2001, through December 31, 2001, and of
its performance under the Indenture has been made, and (ii) to the best of my
knowledge, based on such review, the Issuer has fulfilled all its obligations
under the Indenture throughout such period.



                                       KEYCORP STUDENT LOAN TRUST 1999-B,
                                       as Issuer

                                       By: Bank One, National Association
                                       as Eligible Lender Trustee



                                       By: /S/ JEFFREY L. KINNEY
                                           -------------------------------------
Date:  March 8, 2002                   Name: Jeffrey L. Kinney
                                       Title: Vice President
NUMBER 13-10-00621-CV

COURT OF APPEALS

THIRTEENTH DISTRICT OF TEXAS

CORPUS CHRISTI - EDINBURG

____________________________________________________________

ELVA PEREZ, Appellant,

v.

DEUTSCHE BANK NATIONAL TRUST COMPANY, 

AS TRUSTEE UNDER NOVASTAR MORTGAGE 

FUNDING TRUST, SERIES 2002-2, Appellee. 

____________________________________________________________

On appeal from the 103rd District Court 

of Cameron County, Texas.

____________________________________________________________

MEMORANDUM OPINION

Before Justices Rodriguez, Vela, and Perkes

Memorandum Opinion Per Curiam

The appellant's brief in the above cause was originally due on April 4, 2011. On 

August 18, 2011, this Court ordered the appellate brief to be filed on or before September 

19, 2011. The order notified counsel that no further extensions would be granted and 
2

that if the brief was not filed, the appeal was subject to dismissal for want of prosecution 

under Texas Rule of Appellate Procedure 38.8(a)(1), unless appellant reasonably 

explained the failure and the appellee was not significantly injured by the appellant's 

failure to timely file a brief. 

Appellant has failed to file her brief or otherwise respond. Accordingly, the appeal 

is DISMISSED FOR WANT OF PROSECUTION. See TEX. R. APP. P. 38.8(a), 42.3(b). 

PER CURIAM

Delivered and filed the

3rd day of November, 2011.
§ 1180.3 General rule. Unless an exception applies under section 1180.7, each federal agency shall, within the time period specified in this regulation, transfer to NTIS— ( a ) At least one copy of every final STEI product resulting from the agency's federally funded research and development activities, and
( b ) A summary of the agency's new and on-going research that is likely to result in a final STEI product
if such final product or summary is unclassified and is intended by the agency for public dissemination.
###### Editorial Note on Part 303

#### Editorial Note:

Nomenclature changes to part 303 appear at 68 FR 56555, Oct. 1, 2003.

#### §§ 303.10-303.11 [Reserved]
# L_2016211EN.01002501.xml

| 4.8.2016 | EN | Official Journal of the European Union | L 211/25 |
| --- | --- | --- | --- |

4.8.2016

EN

Official Journal of the European Union

L 211/25

---

DECISION OF THE EEA JOINT COMMITTEE

No 88/2015

of 30 April 2015

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2016/1271]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Delegated Regulation (EU) No 1252/2014 of 28 May 2014 supplementing Directive 2001/83/EC of the European Parliament and of the Council with regard to principles and guidelines of good manufacturing practice for active substances for medicinal products for human use (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Delegated Regulation (EU) No 1252/2014 of 28 May 2014 supplementing Directive 2001/83/EC of the European Parliament and of the Council with regard to principles and guidelines of good manufacturing practice for active substances for medicinal products for human use (1) is to be incorporated into the EEA Agreement.

| (2) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following point is inserted after point 15qc (Commission Delegated Regulation (EU) No 357/2014) of Chapter XIII of Annex II to the EEA Agreement:

| ‘15qd. | 32014 R 1252: Commission Delegated Regulation (EU) No 1252/2014 of 28 May 2014 supplementing Directive 2001/83/EC of the European Parliament and of the Council with regard to principles and guidelines of good manufacturing practice for active substances for medicinal products for human use (OJ L 337, 25.11.2014, p. 1).’ |
| --- | --- |

‘15qd.

Article 2

The text of Delegated Regulation (EU) No 1252/2014 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 1 May 2015, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 30 April 2015.

For the EEA Joint Committee

The President

Gianluca GRIPPA

---

(1)  
  OJ L 337, 25.11.2014, p. 1.

1

(*1)  No constitutional requirements indicated.

*1

---